Subscribe to our mailing list

Enterprise Information Roundup, Dec. 15


Teva cuts about

14,000 jobs

Teva Prescription drugs, the world’s greatest maker of generic medicine, mentioned Thursday that it could minimize a few quarter of its workforce, or 14,000 jobs, shut manufacturing and analysis services, and droop its dividend because it seeks to simplify its construction and cut back its debt.

The Israeli firm has been squeezed by elevated competitors and decrease costs in a difficult U.S market setting. It minimize its full-year forecast after it reported disappointing ends in the third quarter this 12 months as income from its U.S. generics enterprise fell sharply.

Powered by WPeMatico

Author: Techno Info

VN:F [1.9.22_1171]
Rating: 0.0/10 (0 votes cast)
VN:F [1.9.22_1171]
Rating: 0 (from 0 votes)

Author Spotlight